Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ICU Medical stock | 188.82

Own ICU Medical stock in just a few minutes.

Posted

Fact checked

ICU Medical, Inc is a medical instruments & supplies business based in the US. ICU Medical shares (ICUI) are listed on the NASDAQ and all prices are listed in US Dollars. ICU Medical employs 8,000 staff and has a trailing 12-month revenue of around USD$1.3 billion.

How to buy shares in ICU Medical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for ICU Medical. Find the stock by name or ticker symbol: ICUI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ICU Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$188.82, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ICU Medical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of ICU Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted ICU Medical's share price?

Since the stock market crash in March caused by coronavirus, ICU Medical's share price has had significant negative movement.

Its last market close was USD$188.82, which is 12.47% down on its pre-crash value of USD$215.73 and 19.50% up on the lowest point reached during the March crash when the shares fell as low as USD$158.01.

If you had bought USD$1,000 worth of ICU Medical shares at the start of February 2020, those shares would have been worth USD$860.31 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$998.86.

ICU Medical share price

Use our graph to track the performance of ICUI stocks over time.

ICU Medical shares at a glance

Information last updated 2020-10-20.
Latest market close USD$188.82
52-week range USD$155.36 - USD$236.505
50-day moving average USD$191.0235
200-day moving average USD$193.1397
Wall St. target price USD$222.67
PE ratio 52.5896
Dividend yield N/A (0%)
Earnings per share (TTM) USD$3.85

Buy ICU Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ICU Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ICU Medical price performance over time

Historical closes compared with the close of $188.82 from 2020-11-16

1 week (2020-11-17) 0.30%
1 month (2020-10-23) -2.06%
3 months (2020-08-24) 3.41%
6 months (2020-05-22) -1.16%
1 year (2019-11-22) 0.98%
2 years (2018-11-23) -19.02%
3 years (2017-11-24) -13.35%
5 years (2015-11-24) 70.83%

Is ICU Medical under- or over-valued?

Valuing ICU Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICU Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ICU Medical's P/E ratio

ICU Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 53x. In other words, ICU Medical shares trade at around 53x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ICU Medical's PEG ratio

ICU Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.8765. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICU Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

ICU Medical's EBITDA

ICU Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$236.7 million.

The EBITDA is a measure of a ICU Medical's overall financial performance and is widely used to measure a its profitability.

ICU Medical financials

Revenue TTM USD$1.3 billion
Operating margin TTM 12.35%
Gross profit TTM USD$488.2 million
Return on assets TTM 5.56%
Return on equity TTM 6.08%
Profit margin 6.61%
Book value $67.434
Market capitalisation USD$4 billion

TTM: trailing 12 months

Shorting ICU Medical shares

There are currently 262,444 ICU Medical shares held short by investors – that's known as ICU Medical's "short interest". This figure is 12.2% down from 298,919 last month.

There are a few different ways that this level of interest in shorting ICU Medical shares can be evaluated.

ICU Medical's "short interest ratio" (SIR)

ICU Medical's "short interest ratio" (SIR) is the quantity of ICU Medical shares currently shorted divided by the average quantity of ICU Medical shares traded daily (recently around 152583.72093023). ICU Medical's SIR currently stands at 1.72. In other words for every 100,000 ICU Medical shares traded daily on the market, roughly 1720 shares are currently held short.

However ICU Medical's short interest can also be evaluated against the total number of ICU Medical shares, or, against the total number of tradable ICU Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ICU Medical's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 ICU Medical shares in existence, roughly 10 shares are currently held short) or 0.0187% of the tradable shares (for every 100,000 tradable ICU Medical shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ICU Medical.

Find out more about how you can short ICU Medical stock.

ICU Medical share dividends

We're not expecting ICU Medical to pay a dividend over the next 12 months.

Have ICU Medical's shares ever split?

ICU Medical's shares were split on a 3:2 basis on 18 March 2002. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your ICU Medical shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for ICU Medical shares which in turn could have impacted ICU Medical's share price.

ICU Medical share price volatility

Over the last 12 months, ICU Medical's shares have ranged in value from as little as $155.36 up to $236.505. A popular way to gauge a stock's volatility is its "beta".

ICUI.US volatility(beta: 0.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICU Medical's is 0.6691. This would suggest that ICU Medical's shares are less volatile than average (for this exchange).

ICU Medical overview

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site